Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine
Clinical trial NCT05453487 · UNKNOWN
Trial details
- NCT number
- NCT05453487
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2022-10-30
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.